Literature DB >> 29490312

Case Reports of Acne and Homeopathy.

Lawrence C Nwabudike.   

Abstract

BACKGROUND: Acne vulgaris is a self-limiting disorder of the pilosebaceous unit. The aesthetic aspect of the disorder may provoke depression and diminish the quality of life. A number of agents are used for acne treatment, e.g., retinoids, antibiotics, benzoic acid, azelaic acid, and hormones. These agents have side-effects, sometimes severe ones. CASE REPORTS: Presented are 2 cases of severe acne treated with individualized homeopathic medicines. Both patients were treated using the classical method of homeopathy, i.e., a single medicine based on the patient's individual characteristics was prescribed. The cases were documented photographically at onset and during the course of treatment. Both patients went into remission following treatment, and long-term follow-up suggested that the therapy remained efficacious long after cessation of treatment. No significant side effects were noted.
CONCLUSIONS: Homeopathic medicines may be useful as stand-alone treatment of patients with severe acne vulgaris. A case series suggested a remission rate of more than 80% using individualized homeopathic treatment. The treatment remained efficacious long after cessation and is not accompanied by significant side-effects. It is to be hoped that this presentation will stimulate research interest into homeopathic medicines as stand-alone or adjunct treatments of acne.
© 2018 S. Karger GmbH, Freiburg.

Entities:  

Keywords:  Acne; Complementary medicine; Homeopathic medicine; Homeopathy; Natrum muriaticum; Palladium metallicum

Mesh:

Substances:

Year:  2018        PMID: 29490312     DOI: 10.1159/000486309

Source DB:  PubMed          Journal:  Complement Med Res        ISSN: 2504-2092            Impact factor:   1.211


  1 in total

1.  An integrative therapeutic approach to elephantiasis nostras verrucosa: A case report.

Authors:  Lawrence Chukwudi Nwabudike; Olimpia Buzia; Alina Mihaela Elisei; Alin Laurentiu Tatu
Journal:  Exp Ther Med       Date:  2022-02-16       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.